Smith & Nephew (SNNUF) Cash & Current Investments (2009 - 2025)
Smith & Nephew (SNNUF) posted Cash & Current Investments of $577.0 million for Q4 2025, down 13.36% on a QoQ basis from $666.0 million in Q4 2024, and down 13.36% year-over-year from $666.0 million in Q4 2024.
Smith & Nephew (SNNUF) has 11 years of Cash & Current Investments data on file, last reported at $577.0 million in Q4 2025.
- In Q4 2025, Cash & Current Investments fell 13.36% year-over-year to $577.0 million; the TTM figure through Dec 2025 stood at $577.0 million (down 13.36% YoY), while the FY2025 annual figure was $577.0 million, down 13.36% from the prior year.
- Cash & Current Investments fell to $577.0 million in Q4 2025, from $666.0 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $666.0 million in Q4 2024 and bottomed at $39.0 million in Q4 2021.
- A 5-year average of $401.6 million and a median of $397.0 million in 2022 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2022 — Cash & Current Investments surged 917.95% — and 2023, when it decreased 17.13%.
- Year by year, Cash & Current Investments stood at $39.0 million in 2021, then surged by 917.95% to $397.0 million in 2022, then decreased by 17.13% to $329.0 million in 2023, then jumped by 102.43% to $666.0 million in 2024, then decreased by 13.36% to $577.0 million in 2025.
- The last three Cash & Current Investments figures came in at $577.0 million (Q4 2025), $666.0 million (Q4 2024), and $329.0 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.38 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.12 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Smith & Nephew | - | - | - | 577.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 577.00 Mn |
| Jun 28, 2025 | 707.00 Mn |
| Dec 31, 2024 | 666.00 Mn |
| Jun 29, 2024 | 561.00 Mn |
| Dec 31, 2023 | 329.00 Mn |
| Dec 31, 2022 | 397.00 Mn |
| Dec 31, 2021 | 2.44 Bn |
| Dec 31, 2020 | 281.00 Mn |
| Jun 30, 2020 | 1.42 Bn |
| Dec 31, 2019 | 283.00 Mn |
| Dec 31, 2018 | 370.00 Mn |
| Jun 30, 2018 | 1.26 Bn |
| Dec 31, 2017 | 183.00 Mn |
| Dec 31, 2016 | 86.00 Mn |
| Dec 31, 2015 | 135.00 Mn |
| Jun 30, 2015 | 1.19 Bn |
| Dec 31, 2014 | 61.00 Mn |
| Sep 30, 2014 | 126.00 Mn |
| Mar 31, 2014 | 102.00 Mn |
| Dec 31, 2013 | 169.00 Mn |
| Sep 28, 2013 | 138.00 Mn |
| Jun 29, 2013 | 103.00 Mn |
| Mar 31, 2013 | 127.00 Mn |
| Dec 31, 2012 | 163.00 Mn |
| Sep 29, 2012 | 612.00 Mn |
| Jun 30, 2012 | 386.00 Mn |
| Mar 31, 2012 | 258.00 Mn |
| Dec 31, 2011 | 199.00 Mn |
| Sep 30, 2011 | 195.00 Mn |
| Jun 30, 2011 | 195.00 Mn |
| Mar 31, 2011 | 215.00 Mn |
| Dec 31, 2010 | 202.00 Mn |
| Sep 30, 2010 | 174.00 Mn |
| Jun 30, 2010 | 174.00 Mn |
| Mar 31, 2010 | 478.00 Mn |
| Dec 31, 2009 | 13.00 Mn |
| Sep 30, 2009 | 122.00 Mn |
| Jun 30, 2009 | 122.00 Mn |
| Mar 31, 2009 | 198.00 Mn |